Finsbury Worldwide Pharm Tst PLC
25 January 2000
BORROWING FACILITY
The Board of Finsbury Worldwide Pharmaceutical Trust PLC announces that the
Company has entered into an agreement with Allied Irish Banks p.l.c. which has
made available a committed multi-currency revolving credit facility of up to
£25,000,000 for the period to 30 December 2004.
The Company has to date drawn US$ 8.2 million, Euro 5.6 million and Japanese Yen
260.0 million for investment in securities in line with the Company's existing
investment remit.
It was announced in the Company's interim statement that the Board would reserve
a portion of the borrowing available under the new facility to fund repurchases
of the Company's shares. Accordingly, the Company has also drawn £2.4 million
to fund the recent repurchase of one million of the Company's ordinary shares.
For and on behalf of Rea Brothers Limited - Secretary
For further information, please contact:
Mark Mathias
Finsbury Asset Management
Tel. 020 7426 6240
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.